Skip to content

Web-Based Self-Monitoring Activity-Restriction and Relaxation Training Program for Kids With Mild Traumatic Brain Injury

Kids With mTBI Get SMART: Development and Pilot Trial of a Web-Based Self-Monitoring Activity-Restriction and Relaxation Training Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03498495
Acronym
SMART
Enrollment
74
Registered
2018-04-13
Start date
2019-05-12
Completion date
2020-08-31
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury Traumatic Mild

Brief summary

SMART is an interactive web-based program that will allow youth with mild traumatic brain injuries (mTBI) to monitor their symptoms and receive education on problem-solving and coping strategies. This study will evaluate the effectiveness of SMART as a means of improving symptom-management, coping skills, and general well-being during recovery from mTBI. Half of participants will receive the SMART intervention, while half will receive usual care.

Interventions

BEHAVIORALSelf-Monitoring Activity-restriction and Relaxation Training (SMART)

SMART integrates real-time self-monitoring of symptoms and activities with interactive modules designed to increase self-efficacy through psychoeducation and training in problem solving/problem-focused coping strategies.

Sponsors

University of Cincinnati
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 11-18 years old * Sustained mTBI within the past week

Exclusion criteria

* Patient and/or family do not speak and read English * Patient and/or family do not have Internet access * Patient experiencing more severe brain injury (Glasgow coma score \<13) * Patient with more than one moderate extracranial injury * Patients with non-mTBI reasons for altered mental status * Patients with severe pre-existing neurologic or cognitive disorders or other disorders that may impair ability to participate in the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change in quality of life, as measured by the Pediatric Quality of Life Inventory (PedsQL)From baseline to 4 weeks post-injuryThe PedsQL includes 23 items measuring physical, emotional, social, and school functioning.

Secondary

MeasureTime frameDescription
Change in coping strategies, as measured by the Coping Strategies Inventory (CSI-S: Short Form)From baseline to 4 weeks post-injuryThe CSI-S is a coping styles measure and has been used with other pediatric TBI samples. Adolescents rate how much they agree with 32-statements regarding different ways of coping with difficult situations on a 5-point Likert scale. Responses are then grouped into primary subscales reflecting eight different coping strategies (e.g., problem-solving, problem avoidance, social withdrawal, etc.).
Change in self-efficacy for symptom management, as measured by the Self-Efficacy Scale (S-eS)From baseline to 4 weeks post-injuryThis 2-item measure will be developed by the research team based on Bandura's self-efficacy theory. Adolescents will rate their level of confidence that they are able to maintain a plan to manage their symptoms each week
Change in general functioning, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)From baseline to 4 weeks post-injuryPROMIS collects data from the adolescent participant and the parent about the impact a condition has on the adolescent's functioning.
Change in health and behavioral symptoms, as measured by the Health and Behavior Inventory (HBI)From baseline to 4 weeks post-injuryThe HBI is a 20-item questionnaire which includes a variety of cognitive, somatic, emotional, and behavioral symptoms requiring parents and adolescents to rate the frequency of occurrence of each symptom over the past week on a 4-point scale, ranging from never to often.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026